The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
FOXO Signaling Pathways as Therapeutic Targets in Cancer
Open accessAbstract
Many transcription factors play a key role in cellular differentiation and the delineation of cell phenotype.Transcription factors are regulated by phosphorylation, ubiquitination, acetylation/deacetylation and interactions between two or more proteins controlling multiple signaling pathways.These pathways regulate different physiological processes and pathological events, such as cancer and other diseases.The Forkhead box O (FOXO) is one subfamily of the fork head transcription factor family with important roles in cell fate decisions and this subfamily is also suggested to play a pivotal functional role as a tumor suppressor in a wide range of cancers.During apoptosis, FOXOs are involved in mitochondria-dependent and -independent processes triggering the expression of death receptor ligands like Fas ligand, TNF apoptosis ligand and Bcl-XL, bNIP3, Bim from Bcl-2 family members.Different types of growth factors like insulin play a vital role in the regulation of FOXOs.The most important pathway interacting with FOXO in different types of cancers is the PI3K/AKT pathway.Some other important pathways such as the Ras-MEK-ERK, IKK and AMPK pathways are also associated with FOXOs in tumorigenesis.Therapeutically targeting the FOXO signaling pathway(s) could lead to the discovery and development of efficacious agents against some cancers, but this requires an enhanced understanding and knowledge of FOXO transcription factors and their regulation and functioning.This review focused on the current understanding of cell biology of FOXO transcription factors which relates to their potential role as targets for the treatment and prevention of human cancers.We also discuss drugs which are currently being used for cancer treatment along with their target pathways and also point out some potential drawbacks of those drugs, which further signifies the need for development of new drug strategies in the field of cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
IKBKE Phosphorylation and Inhibition of FOXO3a: A Mechanism of IKBKE Oncogenic Function
Guo, J., Tian, W., Shu, S., Xin, Y., Shou, C., & Cheng, J. Q. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063636 · Cited by 47
RetractedTumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
Production of large amounts of hydrogen peroxide by human tumor cells.
Szatrowski, T. P., & Nathan, C. (1991) · PubMed · Cited by 2,526
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Engelman, J. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2664 · Cited by 2,445
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Shaw, R. J., & Cantley, L. C. (2006) · Nature · doi:10.1038/nature04869 · Cited by 2,019
Transcriptional Regulation and Its Misregulation in Disease
Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.014 · Cited by 1,620
Mitogenic Signaling Mediated by Oxidants in Ras-Transformed Fibroblasts
Irani, K., Xia, Y., Zweier, J. L., Sollott, S. J., Der, C. J., Fearon, E. R., Sundaresan, M., Finkel, T., & Goldschmidt-Clermont, P. J. (1997) · Science · doi:10.1126/science.275.5306.1649 · Cited by 1,588
Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress
Kops, G. J. P. L., Dansen, T. B., Polderman, P. E., Saarloos, I., Wirtz, K. W. A., Coffer, P. J., Huang, T.-T., Bos, J. L., Medema, R. H., & Burgering, B. M. T. (2002) · Nature · doi:10.1038/nature01036 · Cited by 1,580
FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress
Tothova, Z., Kollipara, R., Huntly, B. J., Lee, B. H., Castrillon, D. H., Cullen, D. E., McDowell, E. P., Lazo-Kallanian, S., Williams, I. R., Sears, C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.01.003 · Cited by 1,562
Lin, K., Dorman, J. B., Rodan, A., & Kenyon, C. (1997) · Science · doi:10.1126/science.278.5341.1319 · Cited by 1,495
Cell transformation by the superoxide-generating oxidase Mox1
Suh, Y.-A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. B., Griendling, K. K., & Lambeth, J. D. (1999) · Nature · doi:10.1038/43459 · Cited by 1,480
FOXO transcription factors at the interface between longevity and tumor suppression
Greer, E. L., & Brunet, A. (2005) · Oncogene · doi:10.1038/sj.onc.1209086 · Cited by 1,310
PI3K/Akt and apoptosis: size matters
Franke, T. F., Hornik, C. P., Segev, L., Shostak, G. A., & Sugimoto, C. (2003) · Oncogene · doi:10.1038/sj.onc.1207115 · Cited by 1,184
Calnan, D. R., & Brunet, A. (2008) · Oncogene · doi:10.1038/onc.2008.21 · Cited by 1,170
The emerging roles of forkhead box (Fox) proteins in cancer
Myatt, S. S., & Lam, E. W. F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2223 · Cited by 1,070
FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis
Paik, J.-H., Kollipara, R., Chu, G., Ji, H., Xiao, Y., Ding, Z., Miao, L., Tothova, Z., Horner, J. W., Carrasco, D. R., et al. (2007) · Cell · doi:10.1016/j.cell.2006.12.029 · Cited by 1,032
Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma
Galili, N., Davis, R. J., Fredericks, W. J., Mukhopadhyay, S., Rauscher, F. J., Emanuel, B. S., Rovera, G., & Barr, F. G. (1993) · Nature Genetics · doi:10.1038/ng1193-230 · Cited by 892
IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a
Hu, M. C.-T., Lee, D.-F., Xia, W., Golfman, L. S., Ou-Yang, F., Yang, J.-Y., Zou, Y., Bao, S., Hanada, N., Saso, H., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00302-2 · Cited by 868
Brunet, A., Park, J., Tran, H., Hu, L. S., Hemmings, B. A., & Greenberg, M. E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.952-965.2001 · Cited by 860
mtDNA mutations increase tumorigenicity in prostate cancer
Petros, J. A., Baumann, A. K., Ruiz-Pesini, E., Amin, M. B., Sun, C. Q., Hall, J., Lim, S., Issa, M. M., Flanders, W. D., Hosseini, S. H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408894102 · Cited by 836
FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK
Essers, M. A., Weijzen, S., de Vries‐Smits, A. M., Saarloos, I., de Ruiter, N. D., Bos, J. L., & Burgering, B. M. T. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600476 · Cited by 798
Redox regulation of FoxO transcription factors
Klotz, L.-O., Sánchez-Ramos, C., Prieto-Arroyo, I., Urbánek, P., Steinbrenner, H., & Monsalve, M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.019 · Cited by 747
Functional Interaction Between ß-Catenin and FOXO in Oxidative Stress Signaling
Essers, M. A. G., de Vries-Smits, L. M. M., Barker, N., Polderman, P. E., Burgering, B. M. T., & Korswagen, H. C. (2005) · Science · doi:10.1126/science.1109083 · Cited by 745
Phosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B
Rena, G., Guo, S., Cichy, S. C., Unterman, T. G., & Cohen, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17179 · Cited by 714
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
Yang, J.-Y., Zong, C. S., Xia, W., Yamaguchi, H., Ding, Q., Xie, X., Lang, J.-Y., Lai, C.-C., Chang, C.-J., Huang, W.-C., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1676 · Cited by 697
The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation
van der HEIDE, L. P., HOEKMAN, M. F. M., & SMIDT, M. P. (2004) · Biochemical Journal · doi:10.1042/bj20040167 · Cited by 691
Dijkers, P. F., Medema, R. H., Pals, C., Banerji, L., Thomas, N. S. B., Lam, E. W.-F., Burgering, B. M. T., Raaijmakers, J. A. M., Lammers, J.-W. J., Koenderman, L., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9138-9148.2000 · Cited by 617
Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.
Davis, R. J., D’Cruz, C. M., Lovell, M. A., Biegel, J. A., & Barr, F. G. (1994) · PubMed · Cited by 585
FOXOs, cancer and regulation of apoptosis
Fu, Z., & Tindall, D. J. (2008) · Oncogene · doi:10.1038/onc.2008.24 · Cited by 584
Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells
Guttilla, I. K., & White, B. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.031427 · Cited by 560
Segura, M. F., Hanniford, D., Menendez, S., Reavie, L., Zou, X., Alvarez-Diaz, S., Zakrzewski, J., Blochin, E., Rose, A., Bogunovic, D., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808263106 · Cited by 542
Chong, Z. Z., Li, F., & Maiese, K. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.02.004 · Cited by 536
Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation
Matsuzaki, H., Daitoku, H., Hatta, M., Tanaka, K., & Fukamizu, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934283100 · Cited by 535
Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization
Potente, M., Urbich, C., Sasaki, K.-I., Hofmann, W. K., Heeschen, C., Aicher, A., Kollipara, R., DePinho, R. A., Zeiher, A. M., & Dimmeler, S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23126 · Cited by 531
Nakae, J., Park, B.-C., & Accili, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.15982 · Cited by 470
FOXO Transcription Factors: Their Clinical Significance and Regulation
Wang, Y., Zhou, Y., & Graves, D. T. (2014) · BioMed Research International · doi:10.1155/2014/925350 · Cited by 419
FoxO6, a Novel Member of the FoxO Class of Transcription Factors with Distinct Shuttling Dynamics
Jacobs, F. M. J., van der Heide, L. P., Wijchers, P. J. E. C., Burbach, J. P. H., Hoekman, M. F. M., & Smidt, M. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302804200 · Cited by 341
Myatt, S. S., Wang, J., Monteiro, L. J., Christian, M., Ho, K.-K., Fusi, L., Dina, R. E., Brosens, J. J., Ghaem-Maghami, S., & Lam, E. W.-F. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1891 · Cited by 318
Fredericks, W. J., Galili, N., Mukhopadhyay, S., Rovera, G., Bennicelli, J., Barr, F. G., & Rauscher, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1522 · Cited by 305
Keller, C., Arenkiel, B. R., Coffin, C. M., El-Bardeesy, N., DePinho, R. A., & Capecchi, M. R. (2004) · Genes & Development · doi:10.1101/gad.1244004 · Cited by 304
Tumor suppressor genes and ROS: complex networks of interactions
Vurusaner, B., Poli, G., & Basaga, H. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.035 · Cited by 293
Interaction of FOXO with β-Catenin Inhibits β-Catenin/T Cell Factor Activity
Hoogeboom, D., Essers, M. A. G., Polderman, P. E., Voets, E., Smits, L. M. M., & Burgering, B. M. T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706638200 · Cited by 271
FOXO Forkhead Transcription Factors Induce G2-M Checkpoint in Response to Oxidative Stress
Furukawa-Hibi, Y., Yoshida-Araki, K., Ohta, T., Ikeda, K., & Motoyama, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200256200 · Cited by 270
Nakae, J., Barr, V., & Accili, D. (2000) · The EMBO Journal · doi:10.1093/emboj/19.5.989 · Cited by 267
WOODS, Y. L., RENA, G., MORRICE, N., BARTHEL, A., BECKER, W., GUO, S., UNTERMAN, T. G., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/bj3550597 · Cited by 265
Angiogenesis and Its Therapeutic Opportunities
Yoo, S. Y., & Kwon, S. M. (2013) · Mediators of Inflammation · doi:10.1155/2013/127170 · Cited by 259
The state-of-play and future of platinum drugs
Apps, M. G., Choi, E. H. Y., & Wheate, N. J. (2015) · Endocrine-Related Cancer · doi:10.1530/erc-15-0237 · Cited by 256
Sunters, A., Madureira, P. A., Pomeranz, K. M., Aubert, M., Brosens, J. J., Cook, S. J., Burgering, B. M. T., Coombes, R. C., & Lam, E. W.-F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1997 · Cited by 249
Salinas, M., Diaz, R., Abraham, N. G., Ruiz de Galarreta, C. M., & Cuadrado, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209164200 · Cited by 247
Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion
Rena, G. (2002) · The EMBO Journal · doi:10.1093/emboj/21.9.2263 · Cited by 239
Borkhardt, A., Repp, R., Haas, O. A., Leis, T., Harbott, J., Kreuder, J., Hammermann, J., Henn, T., & Lampert, F. (1997) · Oncogene · doi:10.1038/sj.onc.1200814 · Cited by 238
Chong, Z. Z., Kang, J., & Maiese, K. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705161 · Cited by 237
Chong, Z. Z., & Maiese, K. (2007) · PubMed · doi:10.14670/hh-22.1251 · Cited by 228
Hillion, J., Le Coniat, M., Jonveaux, P., Berger, R., & Bernard, O. A. (1997) · Blood · doi:10.1182/blood.v90.9.3714 · Cited by 207
Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain
Maiese, K., & Chong, Z. Z. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00078-6 · Cited by 189
Lin, H., Dai, T., Xiong, H., Zhao, X., Chen, X., Yu, C., Li, J., Wang, X., & Song, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015797 · Cited by 185
Kajihara, T., Jones, M., Fusi, L., Takano, M., Feroze-Zaidi, F., Pirianov, G., Mehmet, H., Ishihara, O., Higham, J. M., Lam, E. W.-F., et al. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0118 · Cited by 180
Kato, M., Yuan, H., Xu, Z.-G., Lanting, L., Li, S.-L., Wang, M., Hu, M. C.-T., Reddy, M. A., & Natarajan, R. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070754 · Cited by 175
FOXO1 is a tumor suppressor in classical Hodgkin lymphoma
Xie, L., Ushmorov, A., Leithäuser, F., Guan, H., Steidl, C., Färbinger, J., Pelzer, C., Vogel, M. J., Maier, H. J., Gascoyne, R. D., et al. (2012) · Blood · doi:10.1182/blood-2011-09-381905 · Cited by 171
Many forks in the path: cycling with FoxO
Ho, K. K., Myatt, S. S., & Lam, E. W.-F. (2008) · Oncogene · doi:10.1038/onc.2008.23 · Cited by 169
FOXO3a Promotes Tumor Cell Invasion through the Induction of Matrix Metalloproteinases
Störz, P., Döppler, H. R., Copland, J. A., Simpson, K. J., & Toker, A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00077-09 · Cited by 167
Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a
You, H., Yamamoto, K., & Mak, T. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600889103 · Cited by 165
Kashii, Y., Uchida, M., Kirito, K., Tanaka, M., Nishijima, K., Toshima, M., Ando, T., Koizumi, K., Endoh, T., Sawada, K.-I., et al. (2000) · Blood · doi:10.1182/blood.v96.3.941 · Cited by 159
Mitochondria Damage Checkpoint, Aging, and Cancer
Singh, K. K. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1354.022 · Cited by 156
Zheng, W., Kar, S., & Quirion, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002417200 · Cited by 153
Self-citationParry, P. J., Wei, Y. H., & Evans, G. A. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870110203 · Cited by 151
SnapShot:Forkhead Transcription Factors I
Tuteja, G., & Kaestner, K. H. (2007) · Cell · doi:10.1016/j.cell.2007.09.005 · Cited by 145
Chong, Z. Z., Lin, S., & Maiese, K. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000122746.72175.0e · Cited by 141
The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor
Renault, V. M., Thekkat, P. U., Hoang, K., White, J. L., Brady, C. A., Brož, D. K., Venturelli, O. S., Johnson, T. M., Oskoui, P. R., Xuan, Z., et al. (2011) · Oncogene · doi:10.1038/onc.2011.35 · Cited by 141
Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene
Dobson, C., Warren, A. J., Pannell, R., Forster, A. M., & Rabbitts, T. H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.5.843 · Cited by 137
FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of ArfPreprint
Bouchard, C., Lee, S., Paulus-Hock, V., Loddenkemper, C., Eilers, M., & Schmitt, C. A. (2007) · Genes & Development · doi:10.1101/gad.453107 · Cited by 136
Scheijen, B., Ngo, H. T., Kang, H. K., & Griffin, J. D. (2004) · Oncogene · doi:10.1038/sj.onc.1207456 · Cited by 128
Chong, Z. Z., & Maiese, K. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707161 · Cited by 126
Li, Y., Wang, Z. P., Kong, D., Murthy, S., Dou, Q. P., Sheng, S., Reddy, G. P. V., & Sarkar, F. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701978200 · Cited by 124
Forkhead Transcription Factors and Cardiovascular Biology
Papanicolaou, K. N., Izumiya, Y., & Walsh, K. X. (2008) · Circulation Research · doi:10.1161/circresaha.107.164186 · Cited by 121
Erythropoietin and Oxidative Stress
Maiese, K., Chong, Z. Z., Hou, J., & Shang, Y. (2008) · Current Neurovascular Research · doi:10.2174/156720208784310231 · Cited by 120
Wang, F., Marshall, C. B., Yamamoto, K., Li, G., Plevin, M. J., You, H., Mak, T. W., & Ikura, M. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.025 · Cited by 119
Kang, J., Chong, Z. Z., & Maiese, K. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.557 · Cited by 116
Erythropoietin: Elucidating new cellular targets that broaden therapeutic strategies
Maiese, K., Chong, Z. Z., Li, F., & Shang, Y. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.02.002 · Cited by 113
A “FOXO” in sight: Targeting Foxo proteins from conception to cancer
Maiese, K., Chong, Z. Z., Shang, Y., & Hou, J. (2008) · Medicinal Research Reviews · doi:10.1002/med.20139 · Cited by 113
Phosphorylation of p66Shc and forkhead proteins mediates Aβ toxicity
Smith, W. W., Norton, D. D., Gorospe, M., Jiang, H., Nemoto, S., Holbrook, N. J., Finkel, T., & Kusiak, J. W. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200410041 · Cited by 113
Targeting transcription factors: promising new strategies for cancer therapy
Yeh, J., Toniolo, P. A., & Frank, D. A. (2013) · Current Opinion in Oncology · doi:10.1097/01.cco.0000432528.88101.1a · Cited by 112
Wu, Z., Sun, H.-B., Zeng, W., He, J., & Mao, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045825 · Cited by 112
Sunayama, J., Sato, A., Matsuda, K., Tachibana, K., Watanabe, E., Seino, S., Suzuki, K., Narita, Y., Shibui, S., Sakurada, K., et al. (2011) · Stem Cells · doi:10.1002/stem.696 · Cited by 110
Identification of the prosurvival activity of nerve growth factor on cardiac myocytes
Caporali, A., Sala-Newby, G., Meloni, M., Graiani, G., Pani, E., Cristofaro, B., Newby, A., Madeddu, P., & Emanueli, C. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402263 · Cited by 105
Haplotypes in the human Foxo1a and Foxo3a genes; impact on disease and mortality at old age
Kuningas, M., Mägi, R., Westendorp, R. G. J., Slagboom, P. E., Remm, M., & van Heemst, D. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201766 · Cited by 103
Ticchioni, M., Essafi, M., Jeandel, P. Y., Davi, F., Cassuto, J. P., Deckert, M., & Bernard, A. (2007) · Oncogene · doi:10.1038/sj.onc.1210519 · Cited by 102
Foxo3a induces motoneuron death through the Fas pathway in cooperation with JNK
Barthélémy, C., Henderson, C. E., & Pettmann, B. (2004) · BMC Neuroscience · doi:10.1186/1471-2202-5-48 · Cited by 100
Wang, X., Chen, W. R., & Xing, D. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22839 · Cited by 99
Nakamura, T., & Sakamoto, K. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.10.007 · Cited by 97
FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling
Zheng, W., Kar, S., & Quirion, R. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00783.x · Cited by 96
Self-citationLin, S., & Maiese, K. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200103000-00010 · Cited by 94
Kang, J., Chong, Z. Z., & Maiese, K. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10740 · Cited by 94
Resist or die: FOXO transcription factors determine the cellular response to chemotherapy
Gomes, A., Brosens, J. J., & Lam, E. W. ‐. (2008) · Cell Cycle · doi:10.4161/cc.7.20.6920 · Cited by 94
Chong, Z. Z., Li, F.-Q., & Maiese, K. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2006.12.009 · Cited by 93
Jackson, J. G., Kreisberg, J. I., Koterba, A. P., Yee, D., & Brattain, M. G. (2000) · Oncogene · doi:10.1038/sj.onc.1203825 · Cited by 87
Li, F., Chong, Z. Z., & Maiese, K. (2006) · Current Neurovascular Research · doi:10.2174/156720206778018758 · Cited by 86
Kharas, M. G., Deane, J. A., Wong, S., O’Bosky, K. R., Rosenberg, N. E., Witte, O. N., & Fruman, D. A. (2004) · Blood · doi:10.1182/blood-2003-07-2193 · Cited by 85
IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia
Chapuis, N., Park, S., Léotoing, L., Tamburini, J., Verdier, F., Bardet, V., Green, A. S., Willems, L., Agou, F., Ifrah, N., et al. (2010) · Blood · doi:10.1182/blood-2009-12-260711 · Cited by 82
MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1
Yang, X., Shen, G., Cao, L., Jiang, X., Peng, H., Shen, G., Chen, D., & Xue, P. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-909 · Cited by 80
Sisci, D., Maris, P., Cesario, M. G., Anselmo, W., Coroniti, R., Trombino, G. E., Romeo, F., Ferraro, A., Lanzino, M., Aquila, S., et al. (2013) · Cell Cycle · doi:10.4161/cc.26421 · Cited by 78
Lynch, R. L., Konicek, B. W., McNulty, A. M., Hanna, K. R., Lewis, J. E., Neubauer, B. L., & Graff, J. R. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0163 · Cited by 78
Pax3-FKHR Knock-In Mice Show Developmental Aberrations but Do Not Develop Tumors
Lagutina, I. V., Conway, S. J., Sublett, J. E., & Grosveld, G. C. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7204-7216.2002 · Cited by 78
E2F-1 regulates expression of FOXO1 and FOXO3a
Nowak, K., Killmer, K., Gessner, C., & Lutz, W. (2007) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2007.04.001 · Cited by 74
miR-96 regulates FOXO1-mediated cell apoptosis in bladder cancer
Guo, Y., LIU, H., Zhang, H., et al. (2012) · Oncology Letters · doi:10.3892/ol.2012.775 · Cited by 74
Mercado, G., Xia, S. J., Zhang, C., Ahn, E. H., Gustafson, D. M., Lae, M. E., Ladanyi, M., & Barr, F. G. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20554 · Cited by 71
Chong, Z. Z., Li, F., & Maiese, K. (2006) · Current Neurovascular Research · doi:10.2174/156720206776875830 · Cited by 71
Wickenden, J. A., Jin, H., Johnson, M., Gillings, A. S., Newson, C., Austin, M. J., Chell, S. D., Balmanno, K., Pritchard, C. A., & Cook, S. J. (2008) · Oncogene · doi:10.1038/onc.2008.335 · Cited by 69
Chong, Z. Z., Kang, J., Li, F., & Maiese, K. (2005) · Current Neurovascular Research · doi:10.2174/1567202054368317 · Cited by 66
Abid, M. R., Shih, S., Otu, H. H., Spokes, K., Okada, Y., Curiel, D. T., Minami, T., & Aird, W. C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608620200 · Cited by 63
Trastuzumab-Resistant HER2-Driven Breast Cancer Cells Are Sensitive to Epigallocatechin-3 Gallate
Eddy, S. F., Kane, S. E., & Sonenshein, G. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1691 · Cited by 63
Chong, Z. Z., Lin, S., Kang, J., & Maiese, K. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1025158314016 · Cited by 62
Wang, H., Zhou, X., Huang, J., Mu, N., Guo, Z., Wen, Q. J., Wang, R., Chen, S., Feng, Z., & Zheng, W. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3017-9 · Cited by 61
Self-citationMiR-135b promotes proliferation and invasion of osteosarcoma cells via targeting FOXO1
Pei, H., Jin, Z., Chen, S.-G., Sun, X., Yu, J., & Guo, W. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2281-2 · Cited by 60
Kim, S. Y., Yoon, J., Ko, Y. S., Chang, M. S., Park, J., Lee, H. E., Kim, M. A., Kim, J., Kim, W., & Lee, B. L. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-264 · Cited by 57
Won, C. K., Ji, H. H., & Koh, P. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.060 · Cited by 53
Hidden association of Cowden syndrome, PTEN mutation and meningioma frequency
Yakubov, E., Ghoochani, A., Buslei, R., Buchfelder, M., Eyüpoglu, I. Y., & Savaskan, N. E. (2016) · Oncoscience · doi:10.18632/oncoscience.305 · Cited by 53
Kikuchi, S., Nagai, T., Kunitama, M., Kirito, K., Ozawa, K., & Komatsu, N. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00623.x · Cited by 52
Reagan‐Shaw, S., & Ahmad, N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1018 · Cited by 52
MiR-135b promotes proliferation and invasion of osteosarcoma cells via targeting FOXO1
Chen, H. P. J., SunJie, X., & Guo, Y. (2015) · Cited by 51
Inhibition of PI-3K restores nuclear p27Kip1 expression in a mouse model of Kras-driven lung cancer
Kelly‐Spratt, K. S., Staheli, J. P., Gurley, K. E., Hoon-Kim, K., Knoblaugh, S. E., & Kemp, C. J. (2009) · Oncogene · doi:10.1038/onc.2009.226 · Cited by 49
miR-411 contributes the cell proliferation of lung cancer by targeting FOXO1
Zhao, Z., Qin, L., & Li, S. (2015) · Tumor Biology · doi:10.1007/s13277-015-4425-8 · Cited by 49
High Expression of the PAX3-FKHR Oncoprotein Is Required to Promote Tumorigenesis of Human Myoblasts
Xia, S. J., Holder, D. D., Pawel, B., Zhang, C., & Barr, F. G. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090192 · Cited by 48
Polymorphisms in FOXO Gene Family and Association Analysis with BMI
Kim, J., Jung, H. S., Bae, S. W., Kim, J. H., Park, B. L., Choi, Y. H., Cho, H. Y., Cheong, H. S., & Shin, H. D. (2006) · Obesity · doi:10.1038/oby.2006.24 · Cited by 48
Maiese, K., Chong, Z. Z., Shang, Y., & Hou, J. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.7.905 · Cited by 39
Liao, R., Yan, F., Zeng, Z., Farhan, M., Little, P. J., Quirion, R., Srivastava, L. K., & Zheng, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0211-x · Cited by 38
Self-citationYan, F., Liao, R., Farhan, M., Wang, T., Chen, J., Wang, Z., Little, P. J., & Zheng, W. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.027 · Cited by 37
Self-citationDiabetic stress: new triumphs and challenges to maintain vascular longevity
Maiese, K. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.281 · Cited by 36
Słomka, M., Ziemińska, E., & Łazarewicz, J. W. (2008) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2008-1666 · Cited by 34
Cui, M., Huang, Y., Zhao, Y. L., & Zheng, J. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1599-3_11 · Cited by 24
Telomeric Repeat Containing RNA (TERRA): Aging and Cancer
Sinha, S., Shukla, S., Khan, S. U., Farhan, M., Kamal, M. A., & Meeran, S. M. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527314666150317230124 · Cited by 24
Self-citationWeidinger, C., Krause, K., Mueller, K., Klagge, A., Führer, D., & Führer‐Sakel, D. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2453 · Cited by 23
Catarzi, S., Degl’Innocenti, D., Iantomasi, T., Favalli, F., & VINCENZINI, M. T. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8516-5 · Cited by 13
Bernard, R., Getachew, R., Kamato, D., Thach, L., Osman, N., Chan, V., Zheng, W., & Little, P. J. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12530 · Cited by 10
Self-citation
Cited by
Ulgen, E., Ozisik, O., & Sezerman, O. U. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00858 · Cited by 469
N6-methyladenosine methyltransferases: functions, regulation, and clinical potential
Huang, W., Chen, T.-Q., Fang, K., Zeng, Z.-C., Ye, H., & Chen, Y.-Q. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01129-8 · Cited by 275
Ubiquitination: Friend and foe in cancer
Mansour, M. A. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.06.001 · Cited by 273
Inverso, D., Shi, J., Lee, K. H., Jakab, M., Ben-Moshe, S., Kulkarni, S. R., Schneider, M., Wang, G., Komeili, M., Vélez, P. A., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.05.001 · Cited by 114
(2018) · doi:10.1158/2326-6066.cir-17-0712 · Cited by 40
Metadata
- Authors
- Farhan, M., Wang, H., Gaur, U., Little, P. J., Xu, J., & Zheng, W.
- Venue
- International Journal of Biological Sciences
- Publisher
- Ivyspring International Publisher
- Published
- 2017
- Volume
- 13
- Issue
- 7
- Pages
- 815-827
- ISSN
- 1449-2288 (ISSN-L)
- OpenAlex
- W2741309469
- Cited by
- 533
- References
- 137
- FWCI
- 12.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.